Canadian Cancer Trials Group announced IND.234 clinical trial using liquid biopsy technology for prostrate cancer screening
On Nov. 27, 2018, the Canadian Cancer Trials Group announced the IND.234 clinical trial, the first of its…
Pascal Biosciences announced optimization of cannabinoid-derived drug candidates to kill glioblastoma cells
On Nov. 15, 2018, Pascal Biosciences announced the peer reviewed publication of their licensed cannabinoid-derived drug program for…
Prime Minister Trudeau announced federal funding for the Institute for Advanced Medical Isotopes
On Nov. 13, 2018, Canadian Prime Minister Justin Trudeau announced federal funding for the Institute for Advanced Medical…
City of Hope, TGen announced letter of intent to build cell therapy manufacturing facility in Phoenix area
On Nov. 1, 2018, City of Hope, and its affiliate, Translational Genomics Research Institute (TGen), announced a letter…
Pascal Biosciences and the University of Washington announced exclusive license agreement to develop cannabinoid-based medicine for cancer
On Oct. 30, 2018, Pascal Biosciences announced the Company had entered into an exclusive license agreement with the…
Siteman Cancer Center to offer newest form of proton therapy
On Oct. 22, 2018, the Siteman Cancer Center announced a second proton therapy system that would incorporate pencil-beam…
The prevalence of U.S. adult smoking declined to 19.3 percent in 2017
On Nov. 9, 2918, the U.S. Centers for Disease Control and Prevention (CDC) reported an estimated 47.4 million…
Biotechnology | FDA | Vaccine
FDA approved expanded use of Gardasil 9 vaccine to include adults 27 through 45 years old
On Oct. 5, 2018, the FDA announced it had approved a supplemental application for Gardasil 9 (Human Papillomavirus…
St Jude and World Health Organization announce a five-year collaboration to transform cancer care
On Sept. 27, 2018, St.ﾠJude Children’s Hospital and the World Health Organization announced a five-year collaboration to transform…
The Cancer Prevention and Research Institute announced the formation of the 2018 Texas Cancer Plan
On Sept. 25, 2018, the Cancer Prevention and Research Institute of Texas (CPRIT) announced the formation of the…
Knight Cancer Research Building opened a new era in cancer research
On Sept. 7, 2018, Oregon Health & Science University (OHSU) announced the official completion of the Knight Cancer…
The CPRIT established the Collaborative Action Program for Liver Cancer
On Aug. 29, 2018, the Cancer Prevention and Research Institute of Texas (CPRIT) announced it would invest up…
Emory University and GeoVax Labs partnered to develop a vaccine for HPV
On Aug. 2, 2018, Emory University and GeoVax Labs partnered to develop a vaccine for HPV, with an…
Keck School of Medicine announced $26.5 million grant to fund firstﾠ large-scale study on African-American men with prostate cancer
On Jul. 17, 2018, the Keck School of Medicine of USC announced that it was leading a $26.5…
The Fred & Pamela Buffett Cancer Center opened
On Jun. 5, 2018, a new flagship cancer center was established as the Fred & Pamela Buffett Cancer…
Cancer registry managed by Keck School of Medicine of USC received $43.7 million award
On May 21, 2018, the National Cancer Institute awarded Keck School of Medicine of USC and USC Norris…
Karmanos Cancer Institute began renovations to expand services in Farmington Hills
On May 18, 2018, The Barbara Ann Karmanos Cancer Institute announced it will expand its Lawrence and Idell…
Boykin Family Pledges $10 million to Cleveland Clinic’s Taussig Cancer Institute
On May 18, 2018, the Boykin family pledged $10 million to support Cleveland Clinic’s Taussig Cancer Institute. Paula…
UCLA researchers characterized the mechanism of the mammalian EAK-7 gene, or mEAK-7
On May 14, 2018, University of California, Los Angeles (UCLA) researchers characterized the mechanism of the mammalian EAK-7…
The CPRIT announced a Seed Award for early-stage oncology startup companies
On Apr. 30, 2018, the Cancer Prevention and Research Institute of Texas (CPRIT) announced a Seed Award for…
NIH completed in-depth genomic analysis of 33 cancer types
On Apr. 5, 2018, researchers funded by the National Institutes of Health (NIH) announced they had completed a…
Partner Therapeutics acquired Sanofi’s Leukine and Lynnwood manufacturing facility
On Mar. 9, 2018, Boston-based cancer company Partner Therapeutics announced that it had acquired the global rights to…
The CPRIT awarded academic research and prevention grants totaling $73.5 million
On Feb. 21, 2018, the Cancer Prevention and Research Institute of Texas (CPRIT) awarded 49 new academic research…
The University of Michigan Cancer Center was renamed the Rogel Cancer Center
In 2018, the University of Michigan Cancer Center was renamed the Rogel Cancer Center in recognition of a…
The Lombardi Comprehensive Cancer Center became the 16th National Cancer Institute-designated Comprehensive Cancer Center
In 2018, the Lombardi Comprehensive Cancer Center became the 16th National Cancer Institute-designated Comprehensive Cancer Center funded with…
Omahan Donated $3 million for prostate cancer research to Buffett Cancer Center
On Dec. 13, 2017, longtime Omaha art teacher and businessman Gerald “Jerry” Pabst donated $3 million through an…
Biotechnology | Disease | FDA | Oncology | Therapeutics
FDA approved first biosimilar for the treatment of certain breast and stomach cancers
On Dec. 1, 2017, the U.S. Food and Drug Administration (FDA) approved Mylan’s Ogivri (trastuzumab-dkst) as a biosimilar…
Irving Family bequests $700 Million to Columbia and NewYork-Presbyterian for Cancer Research and Care
On Nov. 16, 2017, Columbia University and NewYork-Presbyterian announced that Florence Irving and her late husband, Herbert Irving,…
Siteman Cancer Center became one of the first cancer centers nationwide to offer newly approved CAR-T cell therapy called Yescarta
On Oct. 18, 2017, the Siteman Cancer Center became one of the first cancer centers nationwide to offer…
NIH partners with leading companies to accelerate development of cancer immunotherapies
On Oct. 12, 2017, the NIH and 11 leading biopharmaceutical companies launched the Partnership for Accelerating Cancer Therapies…